Correlation Between Pulmatrix and Acasti Pharma

Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Acasti Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Acasti Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pulmatrix and Acasti Pharma, you can compare the effects of market volatilities on Pulmatrix and Acasti Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Acasti Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Acasti Pharma.

Diversification Opportunities for Pulmatrix and Acasti Pharma

-0.19

Correlation Coefficient

Pulmatrix  Acasti Pharma

Good diversification

The 3 months correlation between Pulmatrix and Acasti is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Acasti Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acasti Pharma and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Acasti Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acasti Pharma has no effect on the direction of Pulmatrix i.e., Pulmatrix and Acasti Pharma go up and down completely randomly.

Pair Corralation between Pulmatrix and Acasti Pharma

Given the investment horizon of 90 days Pulmatrix is expected to generate 1.09 times more return on investment than Acasti Pharma. However, Pulmatrix is 1.09 times more volatile than Acasti Pharma. It trades about -0.02 of its potential returns per unit of risk. Acasti Pharma is currently generating about -0.08 per unit of risk. If you would invest  202.00  in Pulmatrix on February 21, 2024 and sell it today you would lose (5.00) from holding Pulmatrix or give up 2.48% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Pulmatrix  vs.  Acasti Pharma

Pulmatrix

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.

Acasti Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acasti Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in June 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Pulmatrix and Acasti Pharma

The main advantage of trading using opposite Pulmatrix and Acasti Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Acasti Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will offset losses from the drop in Acasti Pharma's long position.

The idea behind Pulmatrix and Acasti Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.